- Published on
Emergency And Acute Medicine – Pyelonephritis
Pyelonephritis is an upper urinary tract infection resulting from bacterial ascent from the lower urinary tract into the renal pelvis and parenchyma. It is primarily a clinical diagnosis. Incidence is lower in males across most age groups, with a male-to-female ratio of approximately 1:50 during reproductive years, approaching 1:1 after the fifth decade. Bilateral infection occurs in up to 25% of cases, so lateralizing findings may be absent.
Escherichia coli accounts for 80–95% of cases. Other uropathogens include Klebsiella, Enterobacter, Citrobacter, Proteus mirabilis, Serratia, Pseudomonas, Staphylococcus saprophyticus, and increasingly Staphylococcus aureus. Complicated infections should be considered in the presence of predisposing factors such as recent instrumentation (catheterization, cystoscopy), urinary retention, obstruction (stones, strictures, prostatic hypertrophy), anatomic abnormalities, vesicoureteral reflux, neurogenic bladder, recurrent UTIs, recent pyelonephritis, diabetes mellitus, immunosuppression, and pregnancy.
Typical symptoms include dysuria, urinary frequency and urgency, flank or back pain, fever, chills, nausea, vomiting, malaise, and costovertebral angle tenderness. Patients may appear ill or dehydrated. Occult pyelonephritis should be suspected when a presumed lower UTI fails to respond to standard therapy. Infants may present only with fever, irritability, lethargy, poor feeding, or jaundice. Elderly patients often present atypically, with nausea, vomiting, diarrhea, fever, or altered mental status rather than classic urinary symptoms.
Urinalysis is essential and should be obtained via clean-catch or catheterized specimen when contamination is suspected. Pyuria (≥5–10 WBCs per high-power field), leukocyte esterase, and nitrites support the diagnosis, although nitrites may be absent with non–nitrate-reducing organisms. White blood cell casts suggest renal involvement. Urine culture and sensitivity should be obtained in suspected pyelonephritis, unclear diagnoses, treatment failures, recurrent infections, males, and high-risk patients. Greater than 100,000 CFU/mL is considered positive, though lower counts (10²–10⁴ CFU/mL) may be significant in appropriate clinical contexts.
CBC may show leukocytosis but does not confirm upper tract infection. Blood cultures are reserved for septic patients. Chemistry panels are indicated in patients with significant vomiting, dehydration, or comorbidities affecting electrolytes or renal function. Imaging is not routinely required but should be obtained when obstruction, calculi, abscess, or emphysematous pyelonephritis is suspected—particularly in diabetic, elderly, or immunocompromised patients. CT is superior for detecting parenchymal inflammation, obstruction, abscess, or gas formation. Ultrasound is useful for identifying hydronephrosis. MRI may be considered in pregnancy or renal failure.
Initial management focuses on stabilization. Ill or septic patients require IV access and fluid resuscitation with 0.9% normal saline (500 mL–1 L in adults; 20 mL/kg in children), while avoiding fluid overload in those with heart or renal failure.
Parenteral antibiotics are indicated for patients unable to tolerate oral therapy, those who are toxic-appearing, pregnant, immunocompromised, obstructed, or failing outpatient therapy. Empiric IV options include ceftriaxone, fluoroquinolones (adults only), aminoglycoside plus ampicillin, or piperacillin–tazobactam. In pregnancy, third-generation cephalosporins, cefazolin, or ampicillin plus gentamicin are preferred.
Stable, nontoxic patients may be treated as outpatients with oral antibiotics for 7–14 days. Options include ciprofloxacin 500 mg twice daily, ciprofloxacin extended release 1,000 mg daily, levofloxacin 750 mg daily for 5 days, ofloxacin 200 mg twice daily, or amoxicillin/clavulanate 875/125 mg twice daily. Some clinicians administer a single initial IV dose before starting oral therapy. Antiemetics and analgesics should be provided as needed.
Admission is required for sepsis, toxic appearance, inability to tolerate oral intake, pregnancy, urinary obstruction, indwelling catheter, immunosuppression, diabetes with complications, extremes of age, or failure of outpatient therapy. Discharge may be considered for improving, stable patients who can maintain hydration, tolerate oral medications, have controlled pain, normal renal function, and reliable follow-up within 48–72 hours.
Follow-up is important to review culture results and adjust therapy based on sensitivities. Pediatric patients require follow-up imaging to assess for anatomic abnormalities. Pregnant patients need repeat urinalysis to confirm resolution and may require suppressive therapy. Patients with recurrent infections or resistant organisms should be referred to urology or infectious disease specialists.
Pyelonephritis remains primarily a clinical diagnosis requiring minimal laboratory confirmation in straightforward cases. High-risk populations—including young children, elderly patients, pregnant women, and immunocompromised individuals—require aggressive evaluation and management. Always consider alternative diagnoses such as nephrolithiasis, gynecologic infection, or abdominal aortic aneurysm when presentation is atypical.
Pyelonephritis is an upper urinary tract infection resulting from bacterial ascent from the lower urinary tract into the renal pelvis and parenchyma. It is primarily a clinical diagnosis. Incidence is lower in males across most age groups, with a male-to-female ratio of approximately 1:50 during reproductive years, approaching 1:1 after the fifth decade. Bilateral infection occurs in up to 25% of cases, so lateralizing findings may be absent.
Escherichia coli accounts for 80–95% of cases. Other uropathogens include Klebsiella, Enterobacter, Citrobacter, Proteus mirabilis, Serratia, Pseudomonas, Staphylococcus saprophyticus, and increasingly Staphylococcus aureus. Complicated infections should be considered in the presence of predisposing factors such as recent instrumentation (catheterization, cystoscopy), urinary retention, obstruction (stones, strictures, prostatic hypertrophy), anatomic abnormalities, vesicoureteral reflux, neurogenic bladder, recurrent UTIs, recent pyelonephritis, diabetes mellitus, immunosuppression, and pregnancy.
Typical symptoms include dysuria, urinary frequency and urgency, flank or back pain, fever, chills, nausea, vomiting, malaise, and costovertebral angle tenderness. Patients may appear ill or dehydrated. Occult pyelonephritis should be suspected when a presumed lower UTI fails to respond to standard therapy. Infants may present only with fever, irritability, lethargy, poor feeding, or jaundice. Elderly patients often present atypically, with nausea, vomiting, diarrhea, fever, or altered mental status rather than classic urinary symptoms.
Urinalysis is essential and should be obtained via clean-catch or catheterized specimen when contamination is suspected. Pyuria (≥5–10 WBCs per high-power field), leukocyte esterase, and nitrites support the diagnosis, although nitrites may be absent with non–nitrate-reducing organisms. White blood cell casts suggest renal involvement. Urine culture and sensitivity should be obtained in suspected pyelonephritis, unclear diagnoses, treatment failures, recurrent infections, males, and high-risk patients. Greater than 100,000 CFU/mL is considered positive, though lower counts (10²–10⁴ CFU/mL) may be significant in appropriate clinical contexts.
CBC may show leukocytosis but does not confirm upper tract infection. Blood cultures are reserved for septic patients. Chemistry panels are indicated in patients with significant vomiting, dehydration, or comorbidities affecting electrolytes or renal function. Imaging is not routinely required but should be obtained when obstruction, calculi, abscess, or emphysematous pyelonephritis is suspected—particularly in diabetic, elderly, or immunocompromised patients. CT is superior for detecting parenchymal inflammation, obstruction, abscess, or gas formation. Ultrasound is useful for identifying hydronephrosis. MRI may be considered in pregnancy or renal failure.
Initial management focuses on stabilization. Ill or septic patients require IV access and fluid resuscitation with 0.9% normal saline (500 mL–1 L in adults; 20 mL/kg in children), while avoiding fluid overload in those with heart or renal failure.
Parenteral antibiotics are indicated for patients unable to tolerate oral therapy, those who are toxic-appearing, pregnant, immunocompromised, obstructed, or failing outpatient therapy. Empiric IV options include ceftriaxone, fluoroquinolones (adults only), aminoglycoside plus ampicillin, or piperacillin–tazobactam. In pregnancy, third-generation cephalosporins, cefazolin, or ampicillin plus gentamicin are preferred.
Stable, nontoxic patients may be treated as outpatients with oral antibiotics for 7–14 days. Options include ciprofloxacin 500 mg twice daily, ciprofloxacin extended release 1,000 mg daily, levofloxacin 750 mg daily for 5 days, ofloxacin 200 mg twice daily, or amoxicillin/clavulanate 875/125 mg twice daily. Some clinicians administer a single initial IV dose before starting oral therapy. Antiemetics and analgesics should be provided as needed.
Admission is required for sepsis, toxic appearance, inability to tolerate oral intake, pregnancy, urinary obstruction, indwelling catheter, immunosuppression, diabetes with complications, extremes of age, or failure of outpatient therapy. Discharge may be considered for improving, stable patients who can maintain hydration, tolerate oral medications, have controlled pain, normal renal function, and reliable follow-up within 48–72 hours.
Follow-up is important to review culture results and adjust therapy based on sensitivities. Pediatric patients require follow-up imaging to assess for anatomic abnormalities. Pregnant patients need repeat urinalysis to confirm resolution and may require suppressive therapy. Patients with recurrent infections or resistant organisms should be referred to urology or infectious disease specialists.
Pyelonephritis remains primarily a clinical diagnosis requiring minimal laboratory confirmation in straightforward cases. High-risk populations—including young children, elderly patients, pregnant women, and immunocompromised individuals—require aggressive evaluation and management. Always consider alternative diagnoses such as nephrolithiasis, gynecologic infection, or abdominal aortic aneurysm when presentation is atypical.
0 Comments
